Acorda Therapeutics, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
10/10
|
1.79 | 57.09 | -96.86% | 0.4943 | +262.14% |
| P/S |
|
0.1614 | 33.5 | -99.52% |
|
|
| P/BV |
|
-0.1202 | 4.61 | -102.61% |
|
|
| P/FCF |
|
-1.47 | 39.66 | -103.72% |
|
|
| Ev/Ebitda |
|
21.37 | -19.46 | -209.83% |
|
|
| Ev/S |
|
1.53 | 22.56 | -93.23% |
|
|
| Ev/FCF |
|
-12.6 | 45.47 | -127.71% |
|
|
| E/P |
|
-12.04 | 0.0172 | -69907.75% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
2/10
|
7.14 | -14.58 | -148.98% | -14.27 | -150.06% |
| ROE |
|
160.08 | 9.48 | 1588.19% |
|
|
| ROA |
|
-214.75 | 0.1068 | -201178.94% |
|
|
| ROIC |
|
-16.87 | 7.63 | -320.97% |
|
|
| ROS |
|
-214.95 | -26.35 | 715.64% |
|
|
| ROCE |
|
14.73 | 13.75 | 7.1% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
0/10
|
22.72 | -3.73 | -709.38% | 9.89 | +129.68% |
| Nеt Debt/Ebitda |
|
19.11 | -3.19 | -698.34% |
|
|
| Debt/Ratio |
|
1.62 | 0.1777 | 812.26% |
|
|
| Debt/Equity |
|
2.33 | 1.57 | 47.95% |
|
|
| Debt/Net Income |
|
-0.755 | 0.8429 | -189.57% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5467 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2387 | -100% |
|
|
| Average dividend growth |
|
0 | 1.55 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4954 | -100% |
|
|
| Average percentage for payments |
|
189.8 | 43.69 | 334.4% |
|
|
| Difference from average difference in sector |
|
-0.5467 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-38.86 | 73.67 | -152.75% | ||
| Growth impulse Ebitda in 5 years |
|
-79.1 | 15.28 | -617.67% | ||
| Growth impulse Net Income in 5 years |
|
-7.38 | -33.08 | -77.69% | ||
| Growth impulse FCF in 5 years |
|
-93.48 | -8.35 | 1019.52% | ||
| Growth impulse EPS in 5 years |
|
491.3 | -64.95 | -856.43% |
IP Score
3.33/10
